EWP
BSX icon

Elevation Wealth Partners’s Boston Scientific BSX Stock Holding History

Elevation Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.95K Sell
233
-253
-52% -$13.7K ﹤0.01% 811
2026
Q1 		$30.5K Buy
486
+341
+235% +$27.3K 0.01% 305
2025
Q4 		$13.8K Buy
145
+28
+24% +$2.75K ﹤0.01% 438
2025
Q3 		$11.4K Buy
+117
New +$12.1K ﹤0.01% 379
2024
Q3 		– Sell
-67
Closed -$5.16K – 489
2024
Q2 		$5.16K Buy
+67
New +$4.9K ﹤0.01% 382

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
MF
Milford Funds Auckland $6.14B AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.66B AUM 33.26% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Elevation Wealth Partners's BSX Position: Q2 2026 in Review

Elevation Wealth Partners reduced its Boston Scientific (BSX) stake by 52% in Q2 2026, selling an estimated $13.7K and leaving 233 shares worth $9.95K. The position accounts for ﹤0.01% of the portfolio, ranked #811.

Elevation Wealth Partners first reported a position in BSX in Q2 2024 and has held it in 5 quarters since. The position peaked at $30.5K in Q1 2026. 495 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Elevation Wealth Partners held 233 shares of Boston Scientific worth $9.95K as of Q2 2026.
  • Elevation Wealth Partners sold 253 Boston Scientific shares in Q2 2026, an estimated $13.7K.
  • Boston Scientific made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q2 2026, its #811 holding.
  • Elevation Wealth Partners first reported a position in Boston Scientific in Q2 2024 and has held it in 5 quarters since.
  • Elevation Wealth Partners's Boston Scientific position peaked at $30.5K in Q1 2026.
  • 495 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.